Andrew Armstrong: WNT pathway alterations in prostate cancer
Andrew Armstrong, Professor of Medicine, Surgery, Pharmacology and Cancer Biology at the Duke Cancer Institute, shared a post on X, about a recent paper by Amanda Broderick et al., commenting:
“Pleased to share our manuscript on WNT pathway alterations in prostate cancer from the multicenter promise registry! Rana McKay, AlvaAjjai and Amanda Broderick at DCI Center for Prostate and Urologic Cancers.”
Clinical implications of Wnt pathway genetic alterations in men with advanced prostate cancer
Journal: Prostate Cancer and Prostate Diseases
Authors: Elizabeth Pan, Jinju Li, Alec Chu, Clara Hwang, Pedro C. Barata, Frank Cameron, Cackowski, Matthew Labriola, Alyssa Ghose, Mehmet Asim Bilen, Deepak Kilari, Bicky Thapa, Michael Piero, Laura Graham, Abhishek Tripathi, Rohan Garje, Vadim S. Koshkin, Erik Hernandez, Tanya B. Dorff, Michael Thomas Schweizer, Ajjai Shivaram Alva, Rana R. McKay and Andrew J. Armstrong.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023